Literature DB >> 28496727

Risk Factors for the Development of Atrial Fibrillation in HIV Infected Patients.

Yaser Elnahar1, Joseph Daoko1, Anthony Al-Dehneh1, Nishant Gupta1, Vincent A DeBari1, Fayez Shamoon1, Constantinos A Costeas1.   

Abstract

Background: Patients with Human Immunodeficiency Virus (HIV) have an array of multi-organ involvement, including cardiovascular disease. CD4 count is one of the best parameters to monitor the severity of HIV disease. The arrythmogenic potential of HIV disease has not been well defined. The aim of the study is to establish whether an association between the severity of HIV and atrial fibrillation (AF) exists.
Methods: Out of a retrospective cohort of 780 HIV patients from January 2006 to December 2008, 40 patients were selected that developed AF during this period .The age and sex matched controls (n=40) were selected for comparison. The comparison between both groups was done using Fischer Exact Test. Bivariate and multivariate analysis was also performed to analyze the results.
Results: The data shows that 47%(19/40) of the patients with HIV who developed AF had CD4 count lower than 250 as compared to 20%(8/40) in the control group (P value = 0.017)
Conclusion: The data supports the presence of a relationship between HIV and AF. Patients with lower CD4 counts are more susceptible to develop AF.

Entities:  

Year:  2012        PMID: 28496727      PMCID: PMC5153193          DOI: 10.4022/jafib.404

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  11 in total

Review 1.  Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment.

Authors:  Vias Markides; Richard J Schilling
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

2.  Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.

Authors:  H B Krentz; G Kliewer; M J Gill
Journal:  HIV Med       Date:  2005-03       Impact factor: 3.180

3.  Dilated cardiomyopathy in HIV-infected patients.

Authors:  S E Lipshultz
Journal:  N Engl J Med       Date:  1998-10-15       Impact factor: 91.245

4.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.

Authors:  E J Benjamin; P A Wolf; R B D'Agostino; H Silbershatz; W B Kannel; D Levy
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

5.  Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City.

Authors:  Judith E Sackoff; David B Hanna; Melissa R Pfeiffer; Lucia V Torian
Journal:  Ann Intern Med       Date:  2006-09-19       Impact factor: 25.391

Review 6.  Cardiac manifestations of acquired immunodeficiency syndrome.

Authors:  P Rerkpattanapipat; N Wongpraparut; L E Jacobs; M N Kotler
Journal:  Arch Intern Med       Date:  2000-03-13

7.  Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA).

Authors:  G Barbaro; G Di Lorenzo; M Soldini; G Giancaspro; B Grisorio; A Pellicelli; G Barbarini
Journal:  Circulation       Date:  1999-08-31       Impact factor: 29.690

8.  High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.

Authors:  Uwe Kühl; Matthias Pauschinger; Michel Noutsias; Bettina Seeberg; Thomas Bock; Dirk Lassner; Wolfgang Poller; Reinhard Kandolf; Heinz-Peter Schultheiss
Journal:  Circulation       Date:  2005-02-07       Impact factor: 29.690

9.  Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS.

Authors:  G Barbaro; G Di Lorenzo; B Grisorio; G Barbarini
Journal:  N Engl J Med       Date:  1998-10-15       Impact factor: 91.245

10.  Infection of the heart by the human immunodeficiency virus.

Authors:  W W Grody; L Cheng; W Lewis
Journal:  Am J Cardiol       Date:  1990-07-15       Impact factor: 2.778

View more
  4 in total

1.  Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy.

Authors:  Daniele Pastori; Ivano Mezzaroma; Pasquale Pignatelli; Francesco Violi; Gregory Y H Lip
Journal:  Br J Clin Pharmacol       Date:  2019-01-11       Impact factor: 4.335

2.  HIV Infection Is Associated with Greater Left Ventricular Mass in the Multicenter AIDS Cohort Study.

Authors:  Elizabeth Hutchins; Ruibin Wang; Sina Rahmani; Rine Nakanishi; Sabina Haberlen; Lawrence Kingsley; Mallory D Witt; Frank Joseph Palella; Lisa Jacobson; Matthew J Budoff; Wendy S Post
Journal:  AIDS Res Hum Retroviruses       Date:  2019-06-03       Impact factor: 2.205

3.  Incidence and risk factors of atrial fibrillation and atrial arrhythmias in people living with HIV: a systematic review and meta-analysis.

Authors:  Dae Yong Park; Seokyung An; Maria Emilia Romero; Amandeep Kaur; Venkatesh Ravi; Henry D Huang; Aviral Vij
Journal:  J Interv Card Electrophysiol       Date:  2022-05-24       Impact factor: 1.759

Review 4.  Stroke and Systemic Thromboembolism Prevention in People Living With Human Immunodeficiency Virus With Atrial Fibrillation: A Review of Its Implications for Clinical Practice.

Authors:  Pilar Vizcarra; Silvia Guillemi; Oghenowede Eyawo; Robert S Hogg; Julio S Montaner; Matthew Bennett
Journal:  CJC Open       Date:  2019-07-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.